International trial shows aficamten outperforms standard beta-blocker therapy in patients with obstructive hypertrophic cardiomyopathy. Ajith Nair, MD, Associate Professor...
Understanding key heart health metrics can empower you to take control of your cardiovascular risk When it comes to heart...
Heart disease is no longer just a concern for older adults—here’s what’s driving the rise in young people. Heart disease...
The Texas Heart Institute (THI) School of Perfusion Technology proudly added eight new talented alumni to the more than 1000...
Summer is here and temperatures are rising. It is more important now than ever to protect yourself from dehydration and...
On the evening of June 6, 2025, The Texas Heart Institute at Baylor College of Medicine (THI) celebrated the accomplishments...
Awardee Griffin Cronk (second from left) with Keri Sprung, MBA, Ann Guercio, CCP, LP, MBA, and James J. Livesay, MD...
Featured in Vascular News: Dr. Gustavo Oderich The Texas Heart Institute at Baylor College of Medicine is proud to share...
More Posts Send Us A Message
Sadly, every day, lives are lost not because lungs aren’t donated—but because donated lungs don’t arrive in time, or arrive...
For more than half a century, and nearly 1,000 graduates, The Texas Heart Institute School of Perfusion Technology has not...
May is American Stroke Month—a reminder that while stroke is one of the most serious health threats in the U.S.,...
Visit U.S. News & World Report
